Burkhart Erin insider trades
Burkhart Erin has filed 14 Form 4s with the SEC that we hold, for Biomarin Pharmaceutical INC (BMRN) (GVP, Chief Accounting Officer) and Gilead Sciences, INC. (GILD) (SVP, Controllership). Across all of them we count 0 purchases worth $0 and 5 sales worth $560.4K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 2,286 shares of Biomarin Pharmaceutical INC worth $205.7K, dated 2024-04-10. The first filing on our record is dated 2022-05-18 and the latest 2026-09-23.
Biomarin Pharmaceutical INC (BMRN)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-04-10 | S, sale reported on Form 4 | 2,286 | $205.7K | 2024-04-12 |
| 2024-08-13 | S, sale reported on Form 4 | 714 | $64.3K | 2024-08-15 |
| 2025-02-24 | S, sale reported on Form 4 | 1,344 | $91.9K | 2025-02-25 |
| 2025-03-19 | S, sale reported on Form 4 | 1,295 | $92.6K | 2025-03-20 |
| 2025-05-20 | S, sale reported on Form 4 | 1,786 | $105.9K | 2025-05-20 |
Gilead Sciences, INC. (GILD)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1927648) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms